MyAverix Finance
SHG · Healthcare
Jiangsu Kanion Pharmaceutical Co Ltd (600557)
Drug Manufacturers - Specialty & Generic
Jiangsu Kanion Pharmaceutical Co Ltd (600557) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $7.61B, P/E ratio is 27.45, net margin is 9.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600557
Jiangsu Kanion Pharmaceutical Co Ltd (600557) — FAQ
What is Jiangsu Kanion Pharmaceutical Co Ltd's market cap?
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a reported market cap of $7.61B (data as of 2026-03-28).
What is 600557's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Kanion Pharmaceutical Co Ltd (600557) is 27.45 (data as of 2026-03-28).
Does Jiangsu Kanion Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Kanion Pharmaceutical Co Ltd (600557). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Kanion Pharmaceutical Co Ltd in?
Jiangsu Kanion Pharmaceutical Co Ltd (600557) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600557 listed on?
600557 is listed on SHG.
What is Jiangsu Kanion Pharmaceutical Co Ltd's net margin?
Jiangsu Kanion Pharmaceutical Co Ltd (600557) reports a net margin of 9.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.